Oakwood Laboratories, LLC

Quick facts

Phase 3 pipeline

• Leuprolide Acetate for Injectable Suspension · Oncology
  Leuprolide acetate is a gonadotropin-releasing hormone (GnRH) agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to decreased testosterone and estrogen production.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Oakwood Laboratories, LLC portfolio CI brief
• Oakwood Laboratories, LLC pipeline updates RSS